Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Borohydride Reduction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel NaBH4/TFA reduction route improves yield to 80% and purity, offering significant cost reduction in API manufacturing.
Patent CN106188203B reveals high-yield testosterone synthesis reducing impurities significantly for reliable supply chain and cost reduction in API manufacturing.
Patent CN1092759A details a safer route to Felbamate via borohydride reduction, offering cost reduction in API manufacturing and high-purity intermediates.
Novel process for L-2-aminopropanol reduces cost and improves yield for Levofloxacin manufacturing supply chain reliability.
Patent CN118652185B reveals a safer TiO2-catalyzed route for p-methoxybenzylamine. Discover cost reduction in pharmaceutical intermediate manufacturing and supply advantages.
Patent CN113527134B reveals a green NaBH4 reduction route for 1-hydroxyaminoanthraquinone, offering high selectivity and cost reduction in dye intermediate manufacturing.
Advanced synthesis method for cis-perhydroisoindole using lithium borohydride offers significant cost and safety advantages for pharmaceutical intermediate supply chains globally.
Advanced patent CN102341367B details a novel two-step synthesis for halogen-substituted benzene dimethanol, offering superior purity and cost-effective manufacturing for global supply chains.
Patent CN102372642A details a safe, scalable route for (1S)-4,5-dimethoxy-1-[(methylamino)methyl]benzocyclobutane, replacing hazardous LiAlH4 with mild borohydride reduction for cost-effective manufacturing.
Patent CN113214045A reveals a novel Grignard-based synthesis for 3,5-bis(trifluoromethyl)benzyl alcohol, offering >99.5% purity and significant cost reduction in API manufacturing.
Patent CN106883133A reveals a safer dapoxetine hydrochloride synthesis route. Achieve high purity and cost reduction in API manufacturing with scalable methods.
Patent CN107245064B details a safer synthesis route for Sofosbuvir intermediates offering high yield and supply chain stability for pharmaceutical manufacturing.
Patent CN104370755A reveals efficient synthesis for Dolutegravir intermediates. Enables cost reduction and scalable supply chain for global pharmaceutical manufacturers.
Patent CN107245064A details safer borohydride reduction for Sofosbuvir intermediates. Achieve high purity and cost reduction in API manufacturing with scalable recovery methods.
Advanced patent CN104961675A enables safer isavuconazole intermediate production. Discover cost-effective, scalable pharmaceutical intermediate manufacturing solutions.
Patent CN104447515A reveals a novel Ceritinib intermediate route avoiding expensive Platinum Dioxide. Discover cost reduction and high-purity supply chain solutions.
Patent CN101704724B reveals a novel synthesis for trans,trans-4-(4'-alkylcyclohexyl)cyclohexyl alcohol. Achieve >99.8% purity and superior yields for LCD manufacturing.
Patent CN101370759B details a high-yield reduction of halogenated terephthalic acids. This process offers significant cost reduction in pharmaceutical intermediates manufacturing through optimized acid workup.
Patent CN104892608B reveals safer Mirtazapine intermediate synthesis. Eliminate hazardous reagents for cost reduction and reliable pharmaceutical intermediates supply.
Patent CN101423474A details a high-yield, two-step synthesis for L-menthyl 3-hydroxybutyrate using mild base catalysis, offering significant cost reduction in flavor manufacturing.